High Blood Pressure/Hypertension Drugs Monitoring and Device Market
High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, Share & Trends Analysis by Drugs (Pulmonary Hypertension Drugs and Systemic Hypertension Drugs), by Monitoring Devices (Aneroid Sphygmomanometers, Mercury Sphygmomanometer, Digital Devices, and Ambulatory BP Monitors), By End-User (Hospitals and Clinics and Homecare), Forecast Period (2026-2035)
Industry Overview
High blood pressure/hypertension drugs monitoring and device market was valued at $30.5 billion in 2025 and is projected to reach $63.7 billion by 2035, growing at a CAGR of 7.6% during the forecast Period (2026-2035). The market is experiencing steady growth, driven by the rising prevalence of hypertension, increasing aging populations, and growing awareness of early cardiovascular risk detection.
The market encompasses antihypertensive drugs such as diuretics, ACE inhibitors, beta-blockers, and calcium channel blockers, alongside monitoring solutions including digital blood pressure monitors, ambulatory BP devices, and wearable technologies. Its key growth factors include lifestyle-related risk factors (obesity, stress, sedentary behavior), expanding home healthcare adoption, technological advancements in connected and AI-enabled monitoring devices, and supportive government initiatives for chronic disease management. Additionally, improved healthcare access in emerging economies and the shift toward preventive and remote patient monitoring continue to strengthen overall market expansion.
Market Dynamics
Rising Hypertension Prevalence and Ageing Populations
The global increase in hypertension and the expanding elderly population drive demand for both antihypertensive drugs and monitoring devices. Higher incidence of cardiovascular disease and age-related hypertension is creating a sustained need for chronic therapies while also pushing adoption of home and clinical blood-pressure monitoring to enable early detection, therapy titration, and long-term management.
Technology Advances and Convergence With Remote Patient Monitoring (RPM)
Improvements in wearable sensors, continuous and cuffless BP measurement technologies, connected home monitors, and cloud/telehealth integration have made monitoring easier, more accurate, and more attractive to providers and payers. That technological convergence (wearables + RPM platforms + analytics) is expanding use cases from outpatient management to post-discharge follow-up and clinical trials and is unlocking higher-value device sales and services.
Market Access, Commercial Expansion and Shifting Care Pathways
Growing investment by device manufacturers, expanded manufacturing and distribution (including entry into high-growth APAC markets), e-commerce channels, and evolving reimbursement/clinical guidelines that favour remote monitoring are increasing market penetration. At the same time, innovation in antihypertensive drugs (new molecular classes and improved safety profiles) keeps drug-market activity high, which, together with broader provider acceptance of device-assisted care, is accelerating overall market growth.
Market Segmentation
- Based on the drugs, the market is segmented into pulmonary hypertension drugs and systemic hypertension drugs.
- Based on the application, the market is segmented into drug discovery & development, diagnostic, prognostic, predictive, and others.
- Based on the disease, the market is segmented into cancer, cardiac, renal, central nervous system disease, and others.
- Based on the end-user, the market is segmented into hospitals, diagnostic centre, and research institutes.
ACE Inhibitors Segment to Grow at a Considerable Market Share
ACE inhibitors within the Drugs segment represent the largest and leading segment in the global high blood pressure/hypertension drugs, monitoring, and device market. This dominance is driven by their long-standing clinical efficacy, strong guideline recommendations as a first-line therapy for hypertension, and their proven benefits in reducing cardiovascular, renal, and diabetic complications. ACE inhibitors are widely prescribed across both developed and emerging markets due to their cost-effectiveness, availability of generics, and high physician and patient acceptance. Their extensive use in monotherapy as well as in combination regimens further strengthens their market share compared to other antihypertensive classes and monitoring devices. Additionally, the rising global prevalence of hypertension, increasing aging population, and growing burden of comorbid conditions such as chronic kidney disease and heart failure continue to reinforce the leadership of ACE inhibitors, making this segment the largest contributor to overall market revenue.
Digital Devices: A Key Segment in Market Growth
Among all monitoring device categories, digital blood pressure monitoring devices represent the single most significant growth segment in the global high blood pressure/hypertension monitoring and device market. This dominance is driven by their ease of use, high adoption in clinics and home care settings, and rapid integration with digital health ecosystems. Unlike aneroid or mercury sphygmomanometers, digital devices require minimal technical expertise, reducing measurement errors and enabling accurate self-monitoring by patients. The growing global burden of hypertension, combined with rising awareness of early diagnosis and regular monitoring, has accelerated demand for user-friendly, automated devices.
Technological advancements such as Bluetooth connectivity, mobile app integration, cloud-based data storage, and compatibility with remote patient monitoring platforms have further enhanced their clinical and consumer appeal. In home care settings, digital BP monitors are increasingly preferred due to the expansion of telemedicine, aging populations, and the shift toward preventive and value-based healthcare models. Additionally, governments and healthcare providers are promoting home-based blood pressure monitoring to reduce hospital visits and improve long-term disease management. Cost-effectiveness, compact design, and regulatory approvals supporting clinical-grade accuracy have strengthened trust among physicians and patients alike. As a result, digital blood pressure monitoring devices are expected to continue driving market growth, outperforming traditional monitoring technologies across both developed and emerging healthcare markets.
Regional Outlook
The global high blood pressure/hypertension drugs monitoring and device market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US is the single country that most strongly dominates the global high blood pressure (hypertension) drugs-monitoring and device market, driven by its large hypertensive population, advanced healthcare infrastructure, high per-capita healthcare spending, and rapid adoption of home and ambulatory monitoring technologies. Widespread awareness of cardiovascular disease, strong reimbursement pathways, and a dense network of hospitals, clinics and outpatient providers create steady institutional demand for ambulatory and clinical-grade monitoring systems, while consumer willingness to purchase validated home BP monitors supports robust retail volumes. The U.S. is also home to many leading device manufacturers, large clinical research activity that drives product validation, and an ecosystem of digital health and telemedicine platforms that integrate drug management with remote monitoring all factors that concentrate market share. Regulatory clarity from agencies and established clinical guidelines encouraging out-of-office blood pressure measurement further reinforce uptake. While Asia–Pacific is the fastest-growing region, current revenue and installed-base data show North America led by the US holding the single largest national share of the market.
Market Players Outlook
The major companies operating in the global high blood pressure/hypertension drugs monitoring and device market include AstraZeneca PLC, Johnson & Johnson, Novartis AG, Omron Healthcare, Pfizer Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In November 2025, AstraZeneca's phase 3 trial of baxdrostat demonstrated a 14 mmHg reduction in blood pressure over 12 weeks, establishing its competitive advantage due to a half-life of 26 to 30 hours. The Bax24 trial, involving 218 patients with treatment-resistant hypertension, showed significant results, meeting its primary endpoint by reducing ambulatory 24-hour average systolic blood pressure compared to a placebo. AstraZeneca acquired baxdrostat's developer, CinCor Pharma, for $1.3 billion in 2023 and presented this data at the American Heart Association 2025 Scientific Sessions.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global high blood pressure/hypertension drugs monitoring and device market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis – Drugs | Monitoring Devices | End User ($ Million)
- High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key High Blood Pressure/Hypertension Drugs Monitoring and Device Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the High Blood Pressure/Hypertension Drugs Monitoring and Device Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market: Impact Analysis
- Market Opportunities
- Opportunities For Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – High Blood Pressure/Hypertension Drugs Monitoring and Device Market Revenue and Share by Manufacturers
- High Blood Pressure/Hypertension Drugs Monitoring and Device Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- AstraZeneca PLC
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Novartis AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Omron Healthcare
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- AstraZeneca PLC
- Key Company Analysis
- Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis by Drugs ($ Million)
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis by Monitoring Devices ($ Million)
- Aneroid Sphygmomanometers
- Mercury Sphygmomanometer
- Digital Devices
- Ambulatory BP Monitors
- Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis by End-User ($ Million)
- Hospitals
- Clinics and Homecare
- Regional Analysis
- North American High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis – Drugs | Monitoring Devices | End User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis – Drugs | Monitoring Devices | End User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis – Drugs | Monitoring Devices | End User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World High Blood Pressure/Hypertension Drugs Monitoring and Device Market Sales Analysis – Drugs | Monitoring Devices | End User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AstraZeneca PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bayer AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim International GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cipla Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Daiichi Sankyo Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy's Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc (GSK)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lupin Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Noden Pharma DAC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novartis AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Viatris Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Drugs, 2025–2035 ($ Million)
2. Global Diuretics Market Research And Analysis By Region, 2025–2035 ($ Million)
3. Global ACE Inhibitors Market Research And Analysis By Region, 2025–2035 ($ Million)
4. Global Calcium Channel Blockers Market Research And Analysis By Region, 2025–2035 ($ Million)
5. Global Beta-adrenergic Blockers Market Research And Analysis By Region, 2025–2035 ($ Million)
6. Global Vasodilators Market Research And Analysis By Region, 2025–2035 ($ Million)
7. Global Other Drug Type Market Research And Analysis By Region, 2025–2035 ($ Million)
8. Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Monitoring Devices, 2025–2035 ($ Million)
9. Global Aneroid Sphygmomanometers Market Research And Analysis By Region, 2025–2035 ($ Million)
10. Global Mercury Sphygmomanometer Market Research And Analysis By Region, 2025–2035 ($ Million)
11. Global Digital Devices Market Research And Analysis By Region, 2025–2035 ($ Million)
12. Global Ambulatory BP Monitors Market Research And Analysis By Region, 2025–2035 ($ Million)
13. Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by End User, 2025–2035 ($ Million)
14. Global High Blood Pressure/Hypertension Drugs Monitoring and Device For Hospitals Market Research And Analysis By Region, 2025–2035 ($ Million)
15. Global High Blood Pressure/Hypertension Drugs Monitoring and Device For Clinics and Homecare Market Research And Analysis By Region, 2025–2035 ($ Million)
16. Global High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Region, 2025–2035 ($ Million)
17. North American High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Drugs, 2025–2035 ($ Million)
18. North American High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Monitoring Devices, 2025–2035 ($ Million)
19. North American High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by End User, 2025–2035 ($ Million)
20. European High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Drugs, 2025–2035 ($ Million)
21. European High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Monitoring Devices, 2025–2035 ($ Million)
22. European High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by End User, 2025–2035 ($ Million)
23. Asia-Pacific High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Drugs, 2025–2035 ($ Million)
24. Asia-Pacific High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Monitoring Devices, 2025–2035 ($ Million)
25. Asia-Pacific High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by End User, 2025–2035 ($ Million)
26. Rest of the World High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Region, 2025–2035 ($ Million)
27. Rest of the World High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Drugs, 2025–2035 ($ Million)
28. Rest of the World High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by Monitoring Devices, 2025–2035 ($ Million)
29. Rest of the World High Blood Pressure/Hypertension Drugs Monitoring and Device Market Research and Analysis by End User, 2025–2035 ($ Million)
1. Global High Blood Pressure/Hypertension Drugs Monitoring And Device Market Share By Drugs, 2025 Vs 2035 (%)
2. Global Diuretics Market Share By Region, 2025 Vs 2035 (%)
3. Global ACE Inhibitors Market Share By Region, 2025 Vs 2035 (%)
4. Global Calcium Channel Blockers Market Share By Region, 2025 Vs 2035 (%)
5. Global Beta-Adrenergic Blockers Market Share By Region, 2025 Vs 2035 (%)
6. Global Vasodilators Market Share By Region, 2025 Vs 2035 (%)
7. Global Other Drug Type Market Share By Region, 2025 Vs 2035 (%)
8. Global High Blood Pressure/Hypertension Drugs Monitoring And Device Market Share By Monitoring Devices, 2025 Vs 2035 (%)
9. Global Aneroid Sphygmomanometers Market Share By Region, 2025 Vs 2035 (%)
10. Global Mercury Sphygmomanometer Market Share By Region, 2025 Vs 2035 (%)
11. Global High Blood Pressure/Hypertension Drugs Monitoring And Device Market Share By End-User, 2025 Vs 2035 (%)
12. Global High Blood Pressure/Hypertension Drugs Monitoring and Device For Hospitals Market Share By Region, 2025 Vs 2035 (%)
13. Global High Blood Pressure/Hypertension Drugs Monitoring and Device For Clinics and Homecare Market Share By Region, 2025 Vs 2035 (%)
14. Global High Blood Pressure/Hypertension Drugs Monitoring And Device Market Share By Region, 2025 Vs 2035 (%)
15. US High Blood Pressure/Hypertension Drugs Monitoring And Device Market Size, 2025–2035 ($ Million)
16. Canada High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
17. UK High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
18. France High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
19. Germany High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
20. Italy High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
21. Spain High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
22. Russia High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
23. Rest Of Europe High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
24. India High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
25. China High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
26. Japan High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
27. South Korea High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
28. Australia And New Zealand High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
29. Asean Economies High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
30. Rest Of Asia-Pacific High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
31. Latin America High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
32. Middle East And Africa High Blood Pressure/Hypertension Drugs Monitoring and Device Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
